Laura Llorach-Pares (Laura Llorach-Parés)

Publication Activity (10 Years)

Years Active: 2017-2020
Publications (10 Years): 5

Top Topics

Metabolic Syndrome

Cerebrospinal Fluid

Cognitive Decline

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Laura Llorach-Pares, Ened Rodriguez-Urgelles, Alfons Nonell-Canals, Jordi Alberch, Conxita Avila, Melchor Sanchez-Martinez, Albert Giralt
Meridianins and Lignarenone B as Potential GSK3β Inhibitors and Inductors of Structural Neuronal Plasticity. Biomolecules 10 (4) (2020)
Elisabet Cuyàs, Juan Gumuzio, Jesús Lozano Sánchez, David Carreras, Sara Verdura, Laura Llorach-Pares, Melchor Sanchez-Martinez, Elisabet Selga, Guillermo Javier Pérez, Fabiana S Scornik, Ramon Brugada, Joaquim Bosch-Barrera, Antonio Segura-Carretero, Ángel G Martin, José Antonio Encinar, Javier A Menendez
Extra Virgin Olive Oil Contains a Phenolic Inhibitor of the Histone Demethylase LSD1/KDM1A. Nutrients 11 (7) (2019)
Elisabet Cuyàs, Sara Verdura, Laura Llorach-Pares, Salvador Fernández-Arroyo, Fedra Luciano-Mateo, Naomí Cabré, Jan Stursa, Lukas Werner, Begoña Martin-Castillo, Benoit Viollet, Jiri Neuzil, Jorge Joven, Alfons Nonell-Canals, Melchor Sanchez-Martinez, Javier A Menendez
Metformin directly targets the H3K27me3 demethylase KDM6A/UTX. Aging cell 17 (4) (2018)
Laura Llorach-Pares, Alfons Nonell-Canals, Conxita Avila, Melchor Sanchez-Martinez
Kororamides, Convolutamines, and Indole Derivatives as Possible Tau and Dual-Specificity Kinase Inhibitors for Alzheimer's Disease: A Computational Study. Marine drugs 16 (10) (2018)
Laura Llorach-Pares, Alfons Nonell-Canals, Melchor Sanchez-Martinez, Conxita Avila
Computer-Aided Drug Design Applied to Marine Drug Discovery: Meridianins as Alzheimer's Disease Therapeutic Agents. Marine drugs 15 (12) (2017)